Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution

Author(s):  Alexander Kenneth S, Kaushik Sarita

Issue:  Mar/Apr 2004 - Overview of USP Chapter <797>
View All Articles in Issue

Page(s):  147-152

Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 1
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 2
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 3
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 4
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 5
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 6

Download in electronic PDF format for $65

Abstract:  Mexiletine hydrochloride is an orally active class I antiarrythmic agent. An extemporaneous solution of mexiletine hydrochloride was prepared for this study. Water was chosen as the vehicle due to the high solubility of the drug in water. Sorbitol, simple syrup and raspberry syrup were used as sweeteners in an attempt to mask the bitter taste of the drug. The solution was analyzed over 91 days of storage at five temperatures, ie, 4, 30, 40, 50 and 60°C. The sample was analyzed at 2, 6, 24 and 48 hours and then at 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84 and 91 days at each designated temperature. The peak area for the mexiletine hydrochloride peak at time t = 0 was taken as 100%; and, accordingly, the percentages of intact drug remaining at each interval were calculated. The log percentage of the drug remaining was plotted against time (in days) at each temperature. The first-order constants for mexiletine hydrochloride at 4, 30, 40, 50 and 60°C were calculated to be -0.0007, -0.0009, -0.0010, -0.0011 and -0.0013, respectively. The Arrhenius plot was obtained by plotting the first-order degradation constants against the reciprocal of the absolute temperatures. The first-order degradation constant for mexiletine hydrochloride at 25°C was found to be 9.053 × 10-4(day-1). The energy of activation for the reaction was calculated to be -8663.88 J/mole. The shelf lives of the formulation at 4 and 25°C were found to be 173.3 and 115.5 days, respectively.

An attempt was made to identify and characterize any degradation products using the high-performance liquid chromatographic-mass spectrometry technique, as none of the degradation products were detected by ultraviolet analysis. However, this attempt was unsuccessful due to coating of the injection port with the sample, which might be due to crystallization of any of the excipients of the formulation under high temperatures. A degradation mechanism has been hypothesized based on either acid or base attack on the parent compound. The products from this degradation are presented.

Related Keywords: Alexander, Kenneth S, PhD, RPh, Kaushik, Sarita, Mexiletine hydrochloride solution, extemporaneous formulation of, Mexiletine hydrochloride solution, stability testing of

Related Categories: GERIATRICS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, QUALITY CONTROL

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution
Alexander Kenneth S
, Kaushik Sarita
Mar/Apr 2004
Pg. 147-152

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Mexiletine Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2006
Pg. 225

Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson
, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2018
Pg. 516-526

Formulation and Stability of Solutions
Akers Michael J
Jan/Feb 2016
Pg. 41-45

Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2013
Pg. 502

Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson
, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli
May/Jun 2020
Pg. 252-262

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions